Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for INFIQ.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
June 30, 2023 -37.41M
March 31, 2023 -28.32M
December 31, 2022 -19.05M
September 30, 2022 -10.87M
June 30, 2022 -1.107M
March 31, 2022 9.982M
December 31, 2021 21.57M
September 30, 2021 32.14M
June 30, 2021 41.54M
March 31, 2021 52.05M
December 31, 2020 -22.99M
September 30, 2020 -14.13M
June 30, 2020 -11.38M
March 31, 2020 -2.252M
December 31, 2019 7.726M
September 30, 2019 18.62M
June 30, 2019 29.57M
March 31, 2019 39.40M
December 31, 2018 52.46M
September 30, 2018 59.77M
June 30, 2018 45.56M
March 31, 2018 45.40M
December 31, 2017 47.73M
September 30, 2017 53.37M
June 30, 2017 58.90M
Date Value
March 31, 2017 73.79M
December 31, 2016 82.45M
September 30, 2016 102.12M
June 30, 2016 118.83M
March 31, 2016 61.65M
December 31, 2015 98.56M
September 30, 2015 133.61M
June 30, 2015 87.26M
March 31, 2015 121.08M
December 31, 2014 209.47M
September 30, 2014 245.52M
June 30, 2014 138.48M
March 31, 2014 173.05M
December 31, 2013 201.28M
September 30, 2013 230.26M
June 30, 2013 259.91M
March 31, 2013 289.36M
December 31, 2012 310.20M
September 30, 2012 179.73M
June 30, 2012 -3.392M
March 31, 2012 6.963M
December 31, 2011 15.43M
September 30, 2011 28.07M
June 30, 2011 38.38M
March 31, 2011 48.56M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Adynxx, Inc. --
OncoSec Medical, Inc. --
Proteonomix, Inc. --
Poniard Pharmaceuticals, Inc. --
Longport, Inc. --